• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely.

作者信息

Spallarossa Paolo, Tini Giacomo, Sarocchi Matteo, Arboscello Eleonora, Grossi Francesco, Queirolo Paola, Zoppoli Gabriele, Ameri Pietro

机构信息

Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino, Genoa, Italy.

University of Genova, Genoa, Italy.

出版信息

J Clin Oncol. 2019 Sep 1;37(25):2201-2205. doi: 10.1200/JCO.18.02464. Epub 2019 May 14.

DOI:10.1200/JCO.18.02464
PMID:31084547
Abstract
摘要

相似文献

1
Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely.免疫检查点抑制剂相关心肌炎的识别与管理：明智使用肌钙蛋白
J Clin Oncol. 2019 Sep 1;37(25):2201-2205. doi: 10.1200/JCO.18.02464. Epub 2019 May 14.
2
Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings.免疫检查点抑制剂引起的暴发性心肌炎：一例伴有病理结果的病例报告
J Thorac Oncol. 2019 Feb;14(2):e36-e38. doi: 10.1016/j.jtho.2018.10.156. Epub 2018 Nov 1.
3
A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.帕博利珠单抗治疗转移性上尿路尿路上皮癌诱发肌炎后发生心肌炎致死一例
Int Heart J. 2020 Sep 29;61(5):1070-1074. doi: 10.1536/ihj.20-162. Epub 2020 Sep 12.
4
Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms.免疫检查点抑制剂相关心肌炎可呈高低级别两种形式。
Mod Pathol. 2020 Jan;33(1):99-108. doi: 10.1038/s41379-019-0363-0. Epub 2019 Sep 18.
5
Severe ophthalmoplegia and myocarditis following the administration of pembrolizumab.帕博利珠单抗给药后出现严重眼肌麻痹和心肌炎。
Eur J Cancer. 2018 Mar;91:171-173. doi: 10.1016/j.ejca.2017.11.026. Epub 2017 Dec 26.
6
Cardiac Troponin I and T in Checkpoint Inhibitor-associated Myositis and Myocarditis.心脏肌钙蛋白 I 和 T 在免疫检查点抑制剂相关肌炎和心肌炎中的作用。
J Immunother. 2021 May 1;44(4):162-163. doi: 10.1097/CJI.0000000000000356.
7
Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy.阿仑单抗治疗因PD-1治疗引起的免疫相关性心肌炎。
N Engl J Med. 2019 Jun 13;380(24):2375-2376. doi: 10.1056/NEJMc1903064.
8
Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti-programmed death 1 antibody.在一名接受抗程序性死亡1抗体治疗的黑色素瘤患者中，出现针对横纹肌和乙酰胆碱受体的抗体，并伴有重症肌无力合并肌炎和心肌炎。
Eur J Cancer. 2019 Jan;106:193-195. doi: 10.1016/j.ejca.2018.10.025. Epub 2018 Dec 5.
9
Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring.帕博利珠单抗诱导的急性心肌炎相关的完全性房室传导阻滞：密切心脏监测的必要性
Intern Med. 2018 Nov 1;57(21):3157-3162. doi: 10.2169/internalmedicine.0255-17. Epub 2018 Jun 6.
10
A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.深入探讨联合检查点阻断和靶向治疗时代的免疫介导性心肌炎。
Eur J Cancer. 2020 Jan;124:15-24. doi: 10.1016/j.ejca.2019.09.009.

引用本文的文献

1
Comparison of the diagnostic and prognostic value of criteria for immune checkpoint inhibitor related myocarditis.免疫检查点抑制剂相关心肌炎标准的诊断和预后价值比较
Cardiooncology. 2025 Mar 27;11(1):30. doi: 10.1186/s40959-025-00327-4.
2
Immune checkpoint inhibitors and pericardial disease: a systematic review.免疫检查点抑制剂与心包疾病：一项系统综述
Cardiooncology. 2024 May 17;10(1):29. doi: 10.1186/s40959-024-00234-0.
3
Immunotherapy-associated cardiovascular toxicities: insights from preclinical and clinical studies.免疫疗法相关的心血管毒性：来自临床前和临床研究的见解
Front Oncol. 2024 Feb 28;14:1347140. doi: 10.3389/fonc.2024.1347140. eCollection 2024.
4
Cardiac magnetic resonance-based layer-specific strain in immune checkpoint inhibitor-associated myocarditis.基于心脏磁共振的免疫检查点抑制剂相关心肌炎的分层应变。
ESC Heart Fail. 2024 Apr;11(2):1061-1075. doi: 10.1002/ehf2.14664. Epub 2024 Jan 19.
5
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors.免疫检查点抑制剂引起的心脏毒性特征及相关因素的全面综述。
Eur J Med Res. 2023 Nov 8;28(1):495. doi: 10.1186/s40001-023-01464-1.
6
Cardiotoxicity of lung cancer-related immunotherapy versus chemotherapy: a systematic review and network meta-analysis of randomized controlled trials.肺癌相关免疫疗法与化疗的心脏毒性：一项随机对照试验的系统评价和网络荟萃分析
Front Oncol. 2023 Apr 14;13:1158690. doi: 10.3389/fonc.2023.1158690. eCollection 2023.
7
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study.接受免疫检查点抑制剂治疗患者的广泛心血管特征及随访：一项前瞻性多中心研究
Pharmaceuticals (Basel). 2023 Apr 20;16(4):625. doi: 10.3390/ph16040625.
8
A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer.非小细胞肺癌中发生亚临床免疫检查点抑制剂相关性心肌炎 1 例
BMC Pulm Med. 2023 Apr 14;23(1):119. doi: 10.1186/s12890-023-02417-4.
9
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis.免疫检查点抑制剂的心血管效应：不仅仅是心肌炎。
Curr Oncol Rep. 2023 Jul;25(7):743-751. doi: 10.1007/s11912-023-01411-7. Epub 2023 Apr 5.
10
Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block.起搏器与甲基强的松龙脉冲疗法治疗免疫相关性心肌炎合并完全性心脏传导阻滞
Open Med (Wars). 2022 Dec 20;17(1):2109-2116. doi: 10.1515/med-2022-0611. eCollection 2022.